Why is $DYN moving today? · SEC 8-K archive

$DYN SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $DYN: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $DYN filing catalyst

Why did $DYN trigger an AI stock catalyst alert?

$DYN triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Dyne Therapeutics Reports Q3 Net Loss of $193.6M, Cash Runway to Q2 2028. Key points: - Q3 net loss widened to $193.6M ($1.06 per share) vs. $108.0M ($0.76 per share) in prior year due to expanded R&D spend - Cash and marketable securities of $1.134B provide runway into Q2 2028 - BLA for z-rostudirsen in DMD under Priority Review with PDUFA date of January 21, 2027

How did $DYN stock react after the SEC filing?

After the SEC 8-K for $DYN, observed market reaction: T0 price $18.54. Past moves do not guarantee future results.

Where can I get real-time $DYN SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $DYN via Telegram and the VIP Web Terminal from €10/month.

$DYN

$DYN – Dyne Therapeutics Reports Q3 Net Loss of $193.6M, Cash Runway to Q2 2028

Dyne Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $DYN

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 net loss widened to $193.6M ($1.06 per share) vs. $108.0M ($0.76 per share) in prior year due to expanded R&D spend
Cash and marketable securities of $1.134B provide runway into Q2 2028
BLA for z-rostudirsen in DMD under Priority Review with PDUFA date of January 21, 2027

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →